OmniAb (OABI) Short term Debt (2021 - 2026)

OmniAb (OABI) posted quarterly Short term Debt of $1.0 million for Q1 2026, up 183.85% year-over-year from $353000.0 in Q1 2025, and down 4.02% quarter-over-quarter from $1.0 million in Q4 2025.

OmniAb (OABI) Short term Debt (2021 - 2026) Analysis & Trends

OmniAb (OABI) has reported Short term Debt for 6 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Short term Debt rose 183.85% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 183.85% YoY), while the FY2025 annual figure was $1.0 million, up 96.61% from the prior year.
  • Short term Debt eased to $1.0 million in Q1 2026 per OABI's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $4.0 million in Q4 2022 and bottomed at $42631.0 in Q1 2022.
  • Historically, Short term Debt has averaged $1.1 million across 5 years, with a median of $891000.0 in 2024.
  • Annual changes were most pronounced in 2022 — Short term Debt soared 1153220.0% — and 2024, when it tumbled 88.33%.
  • OmniAb's Short term Debt stood at $4.0 million in 2022, then sank by 67.6% to $1.3 million in 2023, then slumped by 59.25% to $531000.0 in 2024, then soared by 96.61% to $1.0 million in 2025, then decreased by 4.02% to $1.0 million in 2026.
  • Business Quant data shows OABI's Short term Debt at $1.0 million in Q1 2026, $1.0 million in Q4 2025, and $719000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 OmniAb 491.42 Mn 439.42 Mn 12.81 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 940,000.00
Mar 31, 2026 1.00 Mn
Dec 31, 2025 1.04 Mn
Sep 30, 2025 719,000.00
Jun 30, 2025 1.12 Mn
Mar 31, 2025 353,000.00
Dec 31, 2024 531,000.00
Sep 30, 2024 510,000.00
Jun 30, 2024 328,000.00
Mar 31, 2024 891,000.00
Dec 31, 2023 1.30 Mn
Sep 30, 2023 1.75 Mn
Jun 30, 2023 2.81 Mn
Mar 31, 2023 2.47 Mn
Dec 31, 2022 4.02 Mn
Sep 30, 2022 88,294.00
Jun 30, 2022 57,666.00
Mar 31, 2022 42,631.00
Dec 31, 2021 2.54 Mn
Jun 30, 2021 5.00